Press Release


Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted
Jun 13, 2022 12:00 JST
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022.
More info..

Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022
May 23, 2022 21:00 JST
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group registered a 211.66% increase in revenue to RM5.08 million for the third quarter ended 31 March 2022 (3Q 2022) compared with revenue of RM1.63 million for the same quarter of the previous financial year.
More info..

Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative
Apr 28, 2022 11:30 JST
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan 2022 programme through a monetary donation to help those in need.
More info..

Personalised Health Supplements Customised from Genetic Screening Results Offered on airasia Super App
Apr 06, 2022 13:00 JST
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical company, is pleased to announce the launch of its genetic screening plus personalised health supplements solutions on the airasia Super App, the region's leading travel & lifestyle digital platform.
More info..

Malaysian Genomics Resource Centre Berhad Awarded Covid-19 Surveillance Contract
Apr 04, 2022 14:00 JST
Malaysian Genomics Resource Centre Berhad ("Malaysian Genomics" or "the Group"), a leading genomics and biopharmaceutical specialist, was recently awarded a COVID-19 surveillance contract by the Institute for Medical Research ("IMR"), the biomedical research arm of the Ministry of Health ("MOH"). Malaysian Genomics is one of the private laboratories that IMR has engaged to outsource genome surveillance of SARS-CoV2.
More info..

Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad
Feb 17, 2022 14:00 JST
Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new substantial shareholder, Bintai Kinden Corporation Berhad ("Bintai Kinden"), a specialist in mechanical and electrical engineering services to the construction sector, in the Group.
More info..

Malaysian Genomics Resource Centre Berhad Records Significant Increase in Revenue of RM7.63 Million
Feb 16, 2022 15:00 JST
Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, today announced that it recorded revenue of RM7.63 million for the second quarter ended 31 December 2021 ("2Q FY2022"), a significant increase of RM7.49 million compared with revenue of RM0.14 million for the corresponding quarter of the previous year.
More info..

Latest Release


More Latest Release >>